Putting an end to inflammation
FAU physician secures 1.5 million euros for cutting-edge research into autoimmune diseases.
Physician Dr. Andreas Ramming from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) has succeeded in securing research funding in one of the toughest European selection processes. Over the next five years, the European Research Council (ERC) will support his outstanding research project with an ERC Starting Grant of 1.5 million euros.
Dr. Andreas Ramming from the Department of Medicine 3 – Rheumatology and Immunology at Universitätsklinikum Erlangen aims to find new approaches to treating autoimmune diseases. With his working group, he is investigating molecular mechanisms that trigger the spread of these diseases to other parts of the body.
During the last few years, Ramming and his team have been collecting data and have discovered the first molecular signatures that seem to foster this serious reaction. The team of physicians now want to investigate further to find out more about the processes behind it and to understand which cells are involved. One thing is already clear: Innate lymphoid cells that were discovered a few years ago play a more important role than was previously suspected.
Ramming and his team aim to pursue the experimental approaches they have drawn up during the past few years and, if possible, to design a completely new type of therapy for autoimmune diseases that contributes to preventing inflammation from spreading in the first place instead of treating it symptomatically after it has started.
‘There are currently no treatments available to stop the disease from spreading from the very beginning,’ explains Ramming. ‘It will certainly take some time for us to develop a treatment method, but we hope to make significant progress during the next few years so that we can soon offer some relief to patients suffering from these diseases.’
Read full article at https://www.fau.eu/2019/09/06/header/1-5-million-euros-of-eu-funding-for-cutting-edge-research/